Mexico City.- Health advisers to the United States government indicated that some Americans who received Moderna’s vaccine against Covid-19 should get a half-dose booster to improve their protection against the virus.
The United States Food and Drug Administration (FDA) advisory panel voted unanimously in favor of recommending a booster injection for older adults with other health problems, employment, or life situations that increase your risk of contracting Covid-19.
The recommendation is not binding, but it represents an important step toward expanding the booster campaign across the country for millions more Americans.
Moderna is seeking approval for a booster injection that includes 50 micrograms of vaccine, half the strength of her regular dose but still higher than the Pfizer-BioNTech injection, which contains 30 micrograms of vaccine.
Committee member Dr. Ofer Levy said it is important to remember that the United States and Israel are different populations and that the vaccine Israel used is different, but added that because they both use similar messenger RNA or mRNA technology, the results of Israel are relevant.
The committee will vote on whether the Moderna booster should be given six months after the second dose to people over the age of 65, as well as to those at high risk of severe Covid-19 and to people aged 18 to 64 who run. the risk of being frequently exposed to coronavirus infections due to their jobs.
If the FDA approves the Moderna booster, the US Centers for Disease Control and Prevention will issue specific recommendations on who should get the vaccines.
They see advances in Israel
Israeli health authorities claimed on Thursday that booster doses of Pfizer-BioNTech’s Covid-19 vaccine improve protection against severe disease in people 40 and older, in presentations made to American scientists.
“What we are seeing is a break in the epidemic curve in Israel,” said Dr. Sharon Alroy-Preis, director of public health services at Israel’s Ministry of Health.
He said the booster vaccination program, which now includes 50 percent of the population across all age groups, is starting to decrease infections even among Israel’s unvaccinated populations.
Israel, which has been rigorously monitoring vaccines in its population, said in a slide presentation that giving a booster dose led to increased protection against confirmed infection in those over 16 years of age.